» Articles » PMID: 38021116

NY-ESO-1 Antigen-antibody Interaction Process Based on an TFBG Plasmonic Sensor

Overview
Specialty Radiology
Date 2023 Nov 29
PMID 38021116
Authors
Affiliations
Soon will be listed here.
Abstract

Autoantibodies against New York esophageal squamous cell cancer 1 (NY-ESO-1) play a crucial role in the diagnosis of esophageal cancer. In this work, a surface plasmonic tilted fiber Bragg grating (TFBG) biosensor is proposed for the detection of NY-ESO-1 antibody, as well as the investigation of the hook effect (which refers to the false negative result in some immunoassays when the concentration of antibodies in the sample is very high) during biomolecular binding between NY-ESO-1 antigen and antibody. The biosensor is made by an 18° TFBG coated with a 50-nm-thick gold film over the fiber surface together with NY-ESO-1 antigens attached to the metallic surface serving as bio-receptors. This biosensor can provide a limit of detection at a concentration of 2 × 10 µg/ml with a good linearity in the range from 2 × 10 to 2 × 10 µg/ml. For a concentration higher than 2 × 10 µg/ml, the performance of the sensor probe is reduced owing to the hook effect. Furthermore, experimental results have also demonstrated the repeatability of the proposed biosensor. This proposed biosensor features label-free, compactness, and fast response, which could be potentially applied in the diagnosis of esophageal cancer.

Citing Articles

Introduction to the feature issue: Advances in Optical Biosensors for Biomedical Applications.

Kumar S, Iadicicco A, Kim S, Tosi D, Marques C Biomed Opt Express. 2024; 15(5):3183-3190.

PMID: 38855687 PMC: 11161368. DOI: 10.1364/BOE.527613.

References
1.
Caucheteur C, Voisin V, Albert J . Polarized spectral combs probe optical fiber surface plasmons. Opt Express. 2013; 21(3):3055-66. DOI: 10.1364/OE.21.003055. View

2.
Loyez M, Hassan E, Lobry M, Liu F, Caucheteur C, Wattiez R . Rapid Detection of Circulating Breast Cancer Cells Using a Multiresonant Optical Fiber Aptasensor with Plasmonic Amplification. ACS Sens. 2020; 5(2):454-463. DOI: 10.1021/acssensors.9b02155. View

3.
Ribaut C, Loyez M, Larrieu J, Chevineau S, Lambert P, Remmelink M . Cancer biomarker sensing using packaged plasmonic optical fiber gratings: Towards in vivo diagnosis. Biosens Bioelectron. 2016; 92:449-456. DOI: 10.1016/j.bios.2016.10.081. View

4.
Liu L, Zhang X, Zhu Q, Li K, Lu Y, Zhou X . Ultrasensitive detection of endocrine disruptors via superfine plasmonic spectral combs. Light Sci Appl. 2021; 10(1):181. PMC: 8423748. DOI: 10.1038/s41377-021-00618-2. View

5.
Kakimoto T, Matsumine A, Kageyama S, Asanuma K, Matsubara T, Nakamura T . Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma. Oncol Lett. 2019; 17(4):3937-3943. PMC: 6403520. DOI: 10.3892/ol.2019.10044. View